Metabolic Health Rewired: Making the GLP-1 Wave Strategic, Not Just Symptomatic

GLP-1 therapies have catalyzed one of the fastest transformations in modern healthcare—expanding from obesity treatment to a broad metabolic health platform. As the market evolves, leaders across pharma, payers, and providers are facing urgent questions about access, affordability, and sustainability. This roundtable explores how organizations are building scalable, evidence-driven strategies that align clinical outcomes with long-term value.

Join us to discuss:

• How are stakeholders defining the next phase of the GLP-1 market—from patient segmentation to value-based access models?

• What infrastructure, care coordination, and data capabilities are required to support large-scale metabolic health programs?

• How can innovation in delivery models, digital engagement, and reimbursement create a more equitable and sustainable ecosystem?